EFTA01419218.pdf

DataSet-10 3 pages 267 words document
V15
👁 1 💬 0
📄 Extracted Text (267 words)
Subject: Trade Report 4/13/2017 [C] From: Vahe Stepanian <~•~> Date: Thu, 13 Apr 2017 10:18:43 -0400 To: Richard Kahn Cc: Darren Indyke Stewart Oldfield Joshua Shoshan Classification: Confidential Rich — following up on the below. Today you executed the following: S 1000 DIS @ $114.12 Nothing done yet on PFE @ $34.60 — PFE currently —$33.95. Please let us know if you have questions. Thank you, Vahe From: Vahe Stepanian Sent: Wednesday, April 05 2017 10:04 AM To: 'Richard Kahn' < Cc: 'Darren Indyke' Stewart Oldfield >; Joshua Shoshan Subject: RE: J Epstein Foundation [C] Classification: Confidential Spoke to Darren to confirm the below GTC orders. Both are currently away from their limits — will let you know if you get executed. Thanks, Vahe EFTA01419218 From: Richard Kahn [mailto: Sent: Wednesday, April 05, 2017 9:36 AM To: Vahe Stepanian Cc: Darren Indyke Subject: 3 Epstein Foundation we need to raise cash for contributions can you please put two good till cancel orders in which darren will confirm sell 1000 Disney at 114.12 or better sell 4200 Pfizer at 34.60 or better thank you Richard Kahn HBRK Associates Inc. 575 Lexington Avenue 4th Floor New tel fax cel EFTA01419219 This communication may contain confidential and/or privileged information. If you are not the intended recipient (or have received this communication in error) please notify the sender immediately and destroy this communication. Any unauthorized copying, disclosure or distribution of the material in this communication is strictly forbidden. Deutsche Bank does not render legal or tax advice, and the information contained in this communication should not be regarded as such. EFTA01419220
ℹ️ Document Details
SHA-256
244d3f2beadd81a8cad25c02222ca636849f80a7139523141618aba6b0d522d0
Bates Number
EFTA01419218
Dataset
DataSet-10
Type
document
Pages
3

Community Rating

Sign in to rate this document

📋 What Is This?

Loading…
Sign in to add a description

💬 Comments 0

Sign in to join the discussion
Loading comments…
Link copied!